176 related articles for article (PubMed ID: 30551487)
1. miR-449a induces EndMT, promotes the development of atherosclerosis by targeting the interaction between AdipoR2 and E-cadherin in Lipid Rafts.
Jiang L; Hao C; Li Z; Zhang P; Wang S; Yang S; Wei F; Zhang J
Biomed Pharmacother; 2019 Jan; 109():2293-2304. PubMed ID: 30551487
[TBL] [Abstract][Full Text] [Related]
2. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway.
Zhang J; Zhu Y; Hu L; Yan F; Chen J
Sci Rep; 2019 May; 9(1):7213. PubMed ID: 31076630
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition.
Wu X; Du X; Yang Y; Liu X; Liu X; Zhang N; Li Y; Jiang X; Jiang Y; Yang Z
Life Sci; 2021 Jan; 265():118816. PubMed ID: 33278397
[TBL] [Abstract][Full Text] [Related]
4. MiR-6835 promoted LPS-induced inflammation of HUVECs associated with the interaction between TLR-4 and AdipoR1 in lipid rafts.
Liu J; Li G; Chen C; Chen D; Zhou Q
PLoS One; 2017; 12(11):e0188604. PubMed ID: 29190778
[TBL] [Abstract][Full Text] [Related]
5. miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT.
Li Q; Peng J; Li X; Leng A; Liu T
Diagn Pathol; 2015 Nov; 10():202. PubMed ID: 26576674
[TBL] [Abstract][Full Text] [Related]
6. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
Zhang H; Hu J; Liu L
Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-142-3p Induces Atherosclerosis-Associated Endothelial Cell Apoptosis by Directly Targeting Rictor.
Qin B; Shu Y; Long L; Li H; Men X; Feng L; Yang H; Lu Z
Cell Physiol Biochem; 2018; 47(4):1589-1603. PubMed ID: 29949787
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
9. [Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7].
Wang HL; Xiao Y; Wu L; Ma DC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):508-513. PubMed ID: 29931899
[TBL] [Abstract][Full Text] [Related]
10. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
Geng H; Guan J
Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
[TBL] [Abstract][Full Text] [Related]
11. MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting Cyclin D2 expression.
Huang R; Hu Z; Cao Y; Li H; Zhang H; Su W; Xu Y; Liang L; Melgiri ND; Jiang L
EBioMedicine; 2019 Feb; 40():685-694. PubMed ID: 30674440
[TBL] [Abstract][Full Text] [Related]
12. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
Chen L; Shang C; Wang B; Wang G; Jin Z; Yao F; Yue Z; Bai L; Wang R; Zhao S; Liu E; Wang W
Biochem Pharmacol; 2021 Oct; 192():114716. PubMed ID: 34339713
[TBL] [Abstract][Full Text] [Related]
13. MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.
Chen SP; Liu BX; Xu J; Pei XF; Liao YJ; Yuan F; Zheng F
BMC Cancer; 2015 Oct; 15():706. PubMed ID: 26471185
[TBL] [Abstract][Full Text] [Related]
14. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
15. Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis.
Qin W; Zhang L; Li Z; Xiao D; Zhang Y; Zhang H; Mokembo JN; Monayo SM; Jha NK; Kopylov P; Shchekochikhin D; Zhang Y
Theranostics; 2020; 10(12):5276-5289. PubMed ID: 32373212
[No Abstract] [Full Text] [Related]
16. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1.
Li Y; Shan F; Chen J
World J Surg Oncol; 2017 Mar; 15(1):69. PubMed ID: 28327197
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
18. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
Correia AC; Moonen JR; Brinker MG; Krenning G
J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
Loyer X; Potteaux S; Vion AC; Guérin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A
Circ Res; 2014 Jan; 114(3):434-43. PubMed ID: 24255059
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM.
Li Q; Yao Y; Shi S; Zhou M; Zhou Y; Wang M; Chiu JJ; Huang Z; Zhang W; Liu M; Wang Q; Tu X
J Cell Mol Med; 2020 Jan; 24(1):910-920. PubMed ID: 31680453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]